Bruker Corporation (BRKR) To Go Ex-Dividend on June 22nd

Bruker Corporation (NASDAQ:BRKR) announced a quarterly dividend on Thursday, May 14th. Shareholders of record on Monday, June 22nd will be given a dividend of 0.05 per share by the medical research company on Tuesday, July 7th. This represents a c) annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, June 22nd.

Bruker has raised its dividend by an average of 0.0%annually over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Research analysts expect Bruker to earn $2.44 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 8.2%.

Bruker Stock Performance

Shares of BRKR opened at $57.23 on Friday. The company has a market cap of $8.71 billion, a PE ratio of -238.46, a price-to-earnings-growth ratio of 1.83 and a beta of 1.31. The company has a current ratio of 1.55, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average price of $46.54 and a 200-day moving average price of $44.14. Bruker has a 12-month low of $28.53 and a 12-month high of $64.54.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.08. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The company had revenue of $823.40 million for the quarter, compared to analysts’ expectations of $795.62 million. During the same period in the prior year, the business earned $0.47 earnings per share. Bruker’s revenue for the quarter was up 2.7% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, equities analysts forecast that Bruker will post 2.12 earnings per share for the current fiscal year.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.